Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-week randomized inpatient trial of HP-3070 in schizophrenia
2015-005134-21Phase 3Completed
- Sponsor
- Noven Pharmaceuticals
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing HP-3070 patch with Placebo patch (2 arms). Primary endpoint: Change in PANSS total score from baseline to Week 6. Started Mar 2016; status: completed.
02
Drugs
Secuado
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2015-005134-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005134-21.